Invention Grant
- Patent Title: 1,2-dithiolane and dithiol compounds useful in treating mutant EGFR-mediated diseases and conditions
-
Application No.: US15873255Application Date: 2018-01-17
-
Publication No.: US10246444B2Publication Date: 2019-04-02
- Inventor: Tarek Suhayl Mansour
- Applicant: Sabila Biosciences LLC
- Applicant Address: US NY New City
- Assignee: SABILA BIOSCIENCES LLC
- Current Assignee: SABILA BIOSCIENCES LLC
- Current Assignee Address: US NY New City
- Agency: Leason Ellis LLP
- Main IPC: C07D409/14
- IPC: C07D409/14 ; C07D409/12 ; C07D215/44 ; A61P35/00 ; C07D401/12
Abstract:
Compositions of the invention comprise 1,2-dithiolane, dithiol and related compounds useful as therapeutic agents for the treatment and prevention of diseases and conditions associated with aberrant EGFR activity.
Public/Granted literature
- US20180208584A1 1,2-DITHIOLANE AND DITHIOL COMPOUNDS USEFUL IN TREATING MUTANT EGFR-MEDIATED DISEASES AND CONDITIONS Public/Granted day:2018-07-26
Information query
